Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.800
+0.040 (0.84%)
Nov 21, 2024, 10:41 AM EST - Market open
Aldeyra Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ALDX stock have an average target of 10, which predicts an increase of 108.33% from the current stock price of 4.80.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 9, 2024.
Analyst Ratings
The average analyst rating for ALDX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +108.33% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +108.33% | Aug 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +108.33% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 | Buy | Reiterates | $10 | +108.33% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $10 | Hold → Buy | Upgrades | $10 | +108.33% | Apr 3, 2024 |
Financial Forecast
Revenue This Year
29.00M
Revenue Next Year
36.35M
from 29.00M
Increased by 25.36%
EPS This Year
-0.68
from -0.64
EPS Next Year
-0.66
from -0.68
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.0M | 105.0M | 135.0M | ||
| Avg | 29.0M | 36.4M | 76.1M | ||
| Low | n/a | n/a | 50.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 262.1% | 271.5% | ||
| Avg | - | 25.4% | 109.4% | ||
| Low | - | - | 39.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.74 | 0.53 | 1.52 | ||
| Avg | -0.68 | -0.66 | 0.11 | ||
| Low | -0.99 | -0.97 | -0.56 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.